Filing Flows

Filing Flows › GE HealthCare Technologies (GEHC) › Recalls, complaints & regulation

GE HealthCare Technologies (GEHC): recalls and clinical trials

GE HealthCare Technologies (GEHC) beyond its filings: 16 recalls in the last 12 months (141 in five years, 12 Class I); 22 active clinical trials.

Latest recalls

GE HealthCare Technologies' latest quarter

GE HealthCare Technologies, Q3 2026: revenue $5.5B (+7% year over year), operating margin 14.6%, net earnings $615M, operating cash flow $907M. The chart follows the revenue to costs, profit and cash.

Questions

Has GE HealthCare Technologies had any recalls?

141 recalls on file over five years from the FDA, CPSC and NHTSA; 16 in the last 12 months.

How many clinical trials does GE HealthCare Technologies have?

22 active studies on ClinicalTrials.gov, 2 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.